These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Mass vaccination: solutions in the skin. Glenn GM; Kenney RT Curr Top Microbiol Immunol; 2006; 304():247-68. PubMed ID: 16989274 [TBL] [Abstract][Full Text] [Related]
10. Effective and lesion-free cutaneous influenza vaccination. Wang J; Li B; Wu MX Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5005-10. PubMed ID: 25848020 [TBL] [Abstract][Full Text] [Related]
11. Optimizing adjuvants for intradermal delivery of MenC glycoconjugate vaccine. Donadei A; Balocchi C; Romano MR; Panza L; Adamo R; Berti F; O'Hagan DT; Gallorini S; Baudner BC Vaccine; 2017 Jul; 35(32):3930-3937. PubMed ID: 28645718 [TBL] [Abstract][Full Text] [Related]
12. An update on the use of laser technology in skin vaccination. Chen X; Wang J; Shah D; Wu MX Expert Rev Vaccines; 2013 Nov; 12(11):1313-23. PubMed ID: 24127871 [TBL] [Abstract][Full Text] [Related]
13. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization. Wei J; Xue W; Yu X; Qiu X; Liu Z J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574 [TBL] [Abstract][Full Text] [Related]
14. Routing dependent immune responses after experimental R848-adjuvated vaccination. van Aalst S; Jansen MAA; Ludwig IS; van der Zee R; van Eden W; Broere F Vaccine; 2018 Mar; 36(11):1405-1413. PubMed ID: 29409680 [TBL] [Abstract][Full Text] [Related]
15. Adjuvants in cutaneous vaccination: A comprehensive analysis. Oladejo M; Tijani AO; Puri A; Chablani L J Control Release; 2024 May; 369():475-492. PubMed ID: 38569943 [TBL] [Abstract][Full Text] [Related]
16. Intrapulmonary (i.pulmon.) Pull Immunization With the Tuberculosis Subunit Vaccine Candidate H56/CAF01 After Intramuscular (i.m.) Priming Elicits a Distinct Innate Myeloid Response and Activation of Antigen-Presenting Cells Than i.m. or i.pulmon. Prime Immunization Alone. Thakur A; Pinto FE; Hansen HS; Andersen P; Christensen D; Janfelt C; Foged C Front Immunol; 2020; 11():803. PubMed ID: 32457748 [TBL] [Abstract][Full Text] [Related]
17. An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems. Puri N; Weyand EH; Abdel-Rahman SM; Sinko PJ Vaccine; 2000 May; 18(23):2600-12. PubMed ID: 10775794 [TBL] [Abstract][Full Text] [Related]
18. New Cutaneous Vaccine Adjuvant that STINGs a Little Less. Caucheteux SM; Piguet V J Invest Dermatol; 2016 Nov; 136(11):2127-2128. PubMed ID: 27772546 [TBL] [Abstract][Full Text] [Related]
19. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment. Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025 [TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of cellular changes in mice after intradermal inoculation with a liposome-iscom adjuvanted vaccine. San Gil F; Turner B; Mullbacher A; Walker MJ; Djordjevic SP; Eamens GJ; Chin JC Scand J Immunol; 1998 Mar; 47(3):243-53. PubMed ID: 9519863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]